Completed NCT03324581
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Beverly Hills Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Terminated NCT05067322
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Device i A study involving a tool, app, wearable, test, or medical device. From 10 Years to 15 Years
Countries
Sponsor Spherix Incorporated
Condition ADHD Completed NCT00510276
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Los Angeles Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 30 Years
Countries United States
Sponsor Eli Lilly and Company
Condition ADHD Withdrawn NCT00931398
This summary needs review. Please check the official study record and contact the research team for details.
In Pittsburgh Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 25 Years
Countries United States
Sponsor University of Pittsburgh
Condition ADHD Completed NCT00191048
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Rolling Hills Estate Why is this study shown? This study is directly about ADHD.
ADHD Drug From 10 Years to 16 Years
Countries United States
Sponsor Eli Lilly and Company
Condition ADHD Recruiting NCT05935722
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Enköping Why is this study shown? This study is directly about ADHD.
ADHD Behavioral
Countries Sweden
Sponsor Örebro University, Sweden
Condition ADHD Completed EUCTR 2005-005330-12
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United Kingdom Why is this study shown? This study is directly about ADHD.
ADHD Drug From 12 Years to 17 Years
Countries United Kingdom
Sponsor King's College London (IOP)
Condition ADHD Completed NCT01174355
This study is completed in Israel. It is testing ND0801 for ADHD.
Multiple locations, including Haifa Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries Israel
Sponsor NeuroDerm Ltd.
Condition ADHD Completed NCT02986672
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Karasjok Why is this study shown? This study is directly about ADHD.
ADHD Other From 6 Years to 16 Years
Countries Norway
Sponsor University Hospital of North Norway
Condition ADHD Unknown NCT02167048
This summary needs review. Please check the official study record and contact the research team for details.
In Vancouver Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 18 Years
Countries Canada
Sponsor University of British Columbia
Condition ADHD Completed NCT06491836
This summary needs review. Please check the official study record and contact the research team for details.
In Cairo Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 6 Years to 16 Years
Countries Egypt
Sponsor Ain Shams University
Condition ADHD Completed NCT03547843
This summary needs review. Please check the official study record and contact the research team for details.
In Trondheim Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 18 Years to 67 Years
Countries Norway
Sponsor Norwegian University of Science and Technology
Condition ADHD